The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ACRV FINANCIAL STATEMENTS

Acrivon Therapeutics, Inc. Common Stock — balance sheet, income statement and cash flow trends

ACRVAcrivon Therapeutics, Inc. Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-75 M-50 M-25 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit228 K $ · Infinity%Operating Income-78.4 M $ · -Infinity%Pre-tax Income-74.2 M $ · -Infinity%Net Income to Owners-74.2 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit228 K $—
Operating Income-78.4 M $—
EBITDA-80 M $—
Net Income to Owners-74.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets99.1 M
  • Equity86.7 M $87%
  • Current Liabilities11.4 M $12%
  • Long-term Liabilities980 K $1%

Key Figures

YoY change
Total Assets99.1 M $-37.5%
Total Liabilities12.4 M $-20.1%
Total Equity86.7 M $-39.4%
Cash & ST Investments90 M $-34.5%
Total Debt2.1 M $-35.2%
Net Debt-39.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-75 M-50 M-25 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-60 M-40 M-20 M0-62.9 M $Operating55.5 M $Investing6.9 M $Financing-484 K $Net Change

Key Figures

YoY change
Operating Cash Flow-62.9 M $—
Capital Expenditures1.2 M $-48.5%
Free Cash Flow-64.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ACRV

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.